Regular Physical Activity and Changes in Risk Factors for Coronary Heart Disease: A Nine Months Prospective Study by Ponjee, Gabriëlle A. E. et al.
Eur J Clin Chem din Biochem 1996; 34:477-483 © 1996 by Walter de Gruyter · Berlin · New York
Regular Physical Activity and
Changes in Risk Factors for Coronary Heart Disease:
A Nine Months Prospective Study
Gabrielle A. E. Ponjee{, Eugene M. E. Janssen2, Jo Hermans3 and Jan W. J. van Wersch4
1
 Diagnostisch Centrum SSDZ, Delft, The Netherlands
2
 Nederlands Sports Instituut Geneeskunde, Arnhem, The Netherlands
3
 University of Leiden, Leiden, The Netherlands
4
 "De Wever" Ziekenhuis, Heerlen, The Netherlands
Summary: This study reports the non-acute effects of a long-term training programme of increasing intensity on
some cardiovascular risk factors and the interrelation between these risk factors. Twenty sedentary men and 14
sedentary women were trained 3 to 4 times a week for nine months. After 36 weeks all individuals ran a half
marathon run. The Wmax, weight, body mass index, systolic and diastolic blood pressure were recorded. The
concentrations of fibrinogen, tissue plasminogen activator, plasminogen activator inhibitor, triacylglycerols, total
cholesterol, LDL cholesterol, HDL cholesterol and lipoprotein(a) were measured. The training programme induced
a median increase in Wraax of 12% in the male group (from 226 to 251.5 Watt) and of 18% in the female group
(from 160 to 188.5 Watt). These increases in Wmax did not correlate with any other property under investigation in
this study. Blood pressure was not altered, but body weight and body mass index were significantly decreased in
the male group (from 74.6 to 72.2 kg and from 23.1 to 22.0 kg/m2, respectively) at the end of the training pro-
gramme and decreased non-significantly in the female group (from 63.0 to 60.7 kg and from 21.6 to 21.5 kg/m2,
respectively). In the male group total cholesterol, low density lipoprotein cholesterol and triacylglycerols decreased
significantly under the influence of the training sessions. Furthermore, in both groups, a great decrease in plasma
plasminogen activator inhibitor concentrations was noticed: in men from 22.5 · 103 AU/1 to 4.5 · 103 AU/1 and in
women from 18.7 · 103 AU/1 to 5.1 · 103 AU/1. However, the changes in the lipid and fibrinolytic quantities were
not correlated with each other. Initial total cholesterol, LDL cholesterol and triacylglycerol levels correlated signifi-
cantly with systolic blood pressure, while diastolic pressure was correlated to tissue plasminogen activator. Since
tissue plasminogen activator also was significantly related to triacylglycerols, a trias existed between primary risk
factors like blood pressure, lipid levels and fibrinolysis. In contrast, the changes in these properties under the
influence of physical training were not interrelated. Median serum lipoprotein(a) concentrations were significantly
increased in both men and women five days before the half marathon run: from 32 mg/1 to 39 mg/1 in men, and
from 65 mg/1 to 125.5 mg/1 in women. Concomitantly, median fibrinogen concentrations were significantly elevated
in men (from 2.32 g/1 to 3.10 g/1) and non-significantly in women (from 2.62 g/1 to 2.93 g/1), although no correlation
existed between the changes in these properties.
In conclusion, the nine months exercise programme increased the aerobic fitness in both men and women as
indicated by the Wmax increase. This improvement coincided but was not correlated with beneficial changes in
several anthropometric, lipid and fibrinolytic properties. Improvement in the risk factors under investigation was
more pronounced in men than in women. The changes in lipid and haemostasis properties did not correlate with
each other. The increases in lipoprotein(a) and fibrinogen concentrations, both atherogenic indices, could actually
present a normal physiological response to the physical strain of exercise training of increasing workload.
Introduction
Atherosclerosis leading to coronary heart disease is still thrombus formation, links the haemostatic system with
the major cause of morbidity and mortality in our West- atherosclerosis at a fundamental level (2-4). Risk
em society (1). Atherosclerosis is a complex multifacto- factors for atherosclerosis are several anthropometric de-
rial disorder, but the pathogenesis includes a contribut- termmants like sex, age, body weight and blood pressure
ing role for blood lipids and haemodynamic forces (5-8). In addition, various biochemical quantities con-
(1-3). Occlusion of an atherosclerotic vessel, based on tribute to the formation of atherosclerotic plaques of
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which hyperlipidaemia, namely an increased serum total
and/or low density lipoprotein cholesterol (LDL choles-
terol) is the best known (7-10). Other properties in-
clude factors of the haemostatic system, like an elevated
plasma fibrinogen or plasminogen activator inhibitor
concentration (11-13). Recently lipoprotein(a), an
LDL-like lipoprotein with a great homology to plasmin-
ogen, a component of the haemostatic system, was des-
ignated as an independent risk factor for the genesis of
artherothrombotic disease (14-17). Regular physical
exercise, among other life-style habits like diet and a
history of no smoking, may reduce the risk of vascular
thrombotic events (6, 18-21). This protection might be
mediated through the effect of exercise on the haemo-
static system and the lipid metabolism, because endu-
rance trained athletes exhibit generally more favourable
values of haemostatic and lipidic variables than their
non-active counterparts (22-25). The results of longitu-
dinal studies, in which selection bias and constitutional
factors have been minimized, are difficult to compare
due to differences in e. g. duration and intensity of the
exercise programmes (23, 26-30). Only few studies ex-
ist on the interrelation of anthropometric, lipid and hae-
mostatic risk factors and the potentially favourable effect
of long-term moderate exercise on these properties
(31-33).
nique of running, stretching, speed, intervals, warming-up and
cooling-down, the training included three elements: long-distance
running, running at high speed and interval training. The elements
followed each other naturally as far as the intensity is concerned.
The intensity was for long-distance runs 70-80% of maximal heart
rate, for running at a fixed pace 80-85% of maximal heart rate
(over 200-2000 m depending on the training status) and for in-
tervals over shorter distances (200-400 m) 95-100% of maximal
heart rate. By putting these three elements together (in relation of
70:20:10 of the distances per week) a gradual undulating
increase of the amount of training can be accomplished by training
to a maximum of 60 min per training sessipn in the first part of
the study and to a maximum of 100 min per training session in the
second part (34).
Sampling
All blood samples were drawn between 8.00 and 9.00 a.m. All
subjects were seated and had not eaten or exercised during the
preceding ten hours before phlebotomy. Samples were taken before
the start of the training programme and, in order to avoid acute
effects, five days before both races. Non-traumatic venipuncture
was performed by trained technicians. Within one hour from sam-
ple collection serum was separated from blood, snap-frozen in ali-
quots, stored at -70 °C in plastic tubes and thawed at 37 °C imme-
diately prior to serial analysis.
Blood pressure
Blood pressure was determined using a standard auscultatory
method by a skilled technician, after a five-minutes rest period
of the subjects in supine position. For the systolic blood pressure
the first Korotkoff sounds were noted, while the diastolic blood
pressure was measured at the disappearance of the Korotkoff
sounds.
The present study was designed to investigate the non-
acute effect of long-term physical conditioning on an-
thropometric and biochemical quantities in previously
sedentary men and women and to evaluate the relation-
ship between the studied components.
Materials and Methods
Subjects
Three hundred seventy people replied to advertisements in two lo-
cal newspapers and on a local radio station. Those who participated
in any sports such as running or jogging or who were active for
more than one hour per week in other recreational sports were
excluded. From the remaining group, twenty males aged from 32
to 49 years (median: 39 years) and 14 females aged from 27-41
years (median: 35 years) were aselectly chosen to participate in the
study. No lipid lowering or antihypertensive medication was used
by any of the volunteers. Among the participants were three female
and six male cigarette smokers (maximum of ten cigarettes a day),
who continued to smoke during the test period. All individuals kept
their diet and other living habits, like the use of alcohol, as constant
as possible during the study. After two information sessions all
subjects gave their written informed consent.
Training programme
After a medical examination and pre-exercise control measure-
ments, all volunteers participated in a 9 months endurance training
programme preparing for a half marathon run (21 km). The training
period lasted 9 months. After 24 and 36 weeks of training all sub-
jects ran a 15 km and 21 km race, respectively. During the general
preparation period the volunteers trained 3-4 times a week; 6
weeks before each contest the training programme was intensified
to 5-6 times a week. Beside the attention paid to style and tech-
Graded maximal exercise tolerance test
Exercise tolerance test was conducted using a Lode bicycle ergo-
meter. The test started at a workload of 50 Watt. After a warming-
up period of 10 minutes, the exercise intensity was increased by
50 Watt every 4 minutes until exhaustion. During the test, subjects
cycled at a rate of approximately 80 min"1 and heart rate was
monitored continuously. W^*1) was calculated as the power step
at which was cycled for the complete 4 minutes, plus the fraction
of power cycled in the final intensity step.
Laboratory procedures
Fibrinogen was determined according to the Clauss method (intra-
assay CV 3.2%; (35)). Reference values, determined in plasma
from 50 healthy volunteers ranged from 2.0 to 4.0 g/1. The antigen
concentrations of the following properties were determined using
an ELISA test method: Tissue plasminogen activator (Kabi Vitrum
Diagnostica, Molndal, Sweden, intra-assay CV 4.9%) and lipopro-
tein(a) (Biopool AB, Umea, Sweden) (36, 37). Reference range for
tissue plasminogen activator, determined in plasma of 50 healthy
volunteers (males and females) was: 0.9—12.1 g/l. The lipopro-
tein(a) assay included ready to use micro-test plates containing af-
finity purified sheep anti-apolipoprotein(a) Ig and sheep anti-apoli-
poprotein(a) peroxidase conjugated Ig (37). Reference range, deter-
mined in serum from 50 healthy volunteers was 0—300 mg/1. The
intra-assay coefficient of variation was 3.1% at a concentration of
150 mg/1 Lp(a) and 4.8% at a concentration of 65 mg/1 Lp(a).
Plasminogen activator inhibitor activity was analyzed using an ex-
cess single chain tissue plasmogen activator and S-2251 as a chro-
mogenic substrate for plasmin (Kabi Vitrum Diagnostica, intra-as-
say CV 9.5%; (38)). Reference ranges determined in 50 healthy
volunteers were: 10.7-32.7 · 103 AU/11)· Serum triacylglycerols
(reference range: 0.8-2.0 mmol/1) and total cholesterol (reference
') Wmax = maximum work load
AU = arbitrary units
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range: 4.0-7.5 mmol/l) were determined using enzymatic assays
(Roche Diagnostica, Basel, Switzerland and Boehringer Mann-
heim, respectively). High density lipoprotein cholesterol (HDL
cholesterol fraction was isolated from serum by the phosphostungs-
ttc acid/magnesium chloride precipitant and determined with a test
kit of Boehringer (39), reference range: 0.9-1.7 mmol/l. Low den-
sity lipoprotein cholesterol (LDL cholesterol) was calculated ac-
cording to the Friedewa/d equation (40), reference range : 3.0-5.0
mmol/l. For all assays of lipids and lipoproteins the intra-assay
coefficients of variation was less than 5%.
Stat is t ics
All statistic computations were done with SPSS/PC+ Statistics 4.0
computer package (SPSS Inc., Chicago, USA). Mlcoxon signed
rank test was used to compare differences in pre- and post-exercise
plasma samples. The Mann-Whitney test was used to compare the
male and female population. All data are given as medians and
interquartile ranges. Correlations between changes in lipids, lipo-
proteins and haemostatic factors and changes in anthropometric
values were calculated according to the method of Spearman (step-
wise). Multiple regression was carried out to find independent de-
terminants for the variations in the increase of Wmax.
Results
Effect of t raining on maximal workload and
the risk factor profiles
Median (interquartile range) initial anthropometric de-
terminants, values of the lipid metabolism, the haemo-
static and fibrinolytic system and the changes in these
properties after nine months of training are summarized
in table 1. In both men and women a nine month training
programme produced a significant increase in Wmax.
In men this increase was 24 Watt = 12% (p < 0.001)
(median change from 226 to 251.5 Watt) and in women
25 Watt = 18% (n.s.) (median change from 160 to
188.5 Watt). In men the median diastolic blood pressure
at rest before and after the training programme was 80
mm Hg. In women median diastolic pressure was shifted
from 72.5 to 77.5 mm Hg (n.s.). In men the median
systolic blood pressure at rest before the training pro-
gramme was 132.5 mm Hg and 9 months later 130 mm
Hg (n. s.). In women the systolic blood pressure shifted
from 120 mm Hg to 125 mm Hg (n.s.). The median
(interquartile range) body weight shifted in the male
population from 74.6 (69.1-79.8) kg at start to 72.2
(64.8-77.7) kg (p < 0.01) at the end of the training pro-
gramme. In the female population from 63.0 (57.0—
65.8) kg to 60.7 (55.0-63.4) kg (n. s.). The median (in-
terquartile range) body mass index shifted in the male
group from 23.1 (21.6-25.5) kg/m2 to 22.0 (21.1-24.4)
kg/m2 (p < 0.01) and in the female group from 21.6
(21.3-22.6) kg/m2 to 21.5 (21.3-22.3) kg/m2 (n.s.).
The lipids showed a significant (p < 0.01) decrease in
Tab. 1 Median (interquartile range) initial anthropometric char-
acteristics and variables of the lipid metabolism and haemostatic
Men
system in men and women and the changes in six months (pre—
post) for these properties.
Initial Change p-value
Wmax (Watt) 20
Weight (kg) 20
Body mass index (kg/m2) 20
Diastolic blood pressure (mm Hg) 20
Systolic blood pressure (mm Hg) 20
Fibrinogen (g/1) 18
Tissue plasminogen activator (μ&/\) 19
Plasminogen activator inhibitor (l O3 AU/1) 17
Triacylglycerols (mmol/l) 20
Total cholesterol (mmol/l) 19
LDL cholesterol (mmol/l) 19
HDL cholesterol (mmol/l) 19
Lipoprotein(a) (mg/1) 20
226 (203-266) 24.0 (8.5-42.0) p < 0.001
74.6 (69.1-79.8) - 1.6 (-3.0-(0.2)) p< 0.001
23.1 (21.6-25.5) - 0.5 (-0.9-0.0) p< 0.001
80 (80-81) 0.0 (-5.0-0.0) p = 0.27
133 (129-146) - 7.5 (-15.0-0.0) p = 0.06
2.32 (1.97-2.48) 0.78 (0.50-1.02) p < 0.001
5.8 (4.7-8.4) 0.10(-2.10-(-0.60)) p = 0.48
22.5 (16.0-26.8) -13,5 (-17.5-(-7.0)) p = 0.001
1.1 (0.9-1.5) - 0.33 (-0.40-(-0.07)) p = 0.001
5.8 (5.0-6.4) - 0.45(-1.15-(-0.2)) ρ < 0.001
4.0 (3.3-4.8) - 0.50 (-1.01-(-0.28)) p = 0.001
1.0 (0.9-.13) 0.0 (-0.10-0.10) p = 0.75
32 (11-63) 39.0 (25.0-68.0) p < 0.001
Women
Initial Change p-value
Wmax (Watt) 14
Weight (kg) 14
Body mass index (kg/m2) 14
Diastolic blood pressure (mm Hg) 14
Systolic blood pressure (mm Hg) 14
Fibrinogen (g/1) 14
Tissue plasminogen activator ^g/i) 14
Plasminogen activator inhibitor (l O3AU/1) 11
Triacylglycerols (mmol/l) 14
Total cholesterol (mmol/l) 14
LDL cholesterol (mmol/l) 14
HDL cholesterol (mmol/l) 14
Lipoprotein(a) (mg/1) 14
160
63.0
21.6
73
120
(152-175)
(57.0-65.8)
(21.3-22.6)
(70-80)
(115-130)
2.62(2.13-3.01)
3.7 (2.7-7.0)
(16.0-25.5)
(0.7-1.1)
(3.9-6.0)
(2.5-3.9)
(1.1-1.9)
(23-199)
18.7
0.9
5.3
3.2
1.5
65
25.0 (17.5-38.5)
- 0.7 (-2.0-0.5)
- 0.2 (-0.7-0.2)
0.0 (-5.0-10.0)
5.0 (-2.5-10.0)
0.31 (-0.21-0.72)
0.45 (-1.70-2.60)
-12.5 (-15.6-(
- 0.10 (-0.24-0.10)
- 0.40 (-1.13-0.08)
- 0.24 (-0.79-0.10)
- 0.10 (-0.25-0.10)
65.5 (31.8-283.3)
p = 0.016
p = 0.10
p = 0.14
p = 0.35
p = 0.25
p = 0.06
p = 0.57
p = 0.003
p = 0.28
p = 0.l6
p = 0.22
p = 0.18
p < 0.001
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triacylglycerols, total cholesterol, and low density lipo-
protein cholesterol (LDL cholesterol) in the male group,
but not in the female population. In contrast, Lp(a) con-
centrations were significantly (p < 0.01) higher in both
men and women after the completion of the training pro-
gramme. In the male group, fibrinogen concentrations
were significantly (p < 0.01) raised after nine months,
while in the female group the rise in median fibrinogen
concentration was not significantly different from pre-
training levels. Finally, in both men and women a large
and highly significant (p < 0.001) decrease in median
plasminogen activator inhibitor levels was observed af-
ter nine months of training.
Correlation analysis
Table 2 shows the correlation (Spearman) between the
change in Wmax and the change in the studied properties
after nine months of training in men and women. No
significant relation existed between the increase in max-
imal workload on a cycle ergometer and the change in
Tab. 2 Spearman's rank coefficient of correlation (r) between the
change in Wmax and the change in the variables of the risk factor
profile after nine months of training.
Change in
Weight (kg)
Body mass index (kg/m2)
Diastolic blood pressure
(mm Hg)
Systolic blood pressure
(mm Hg)
Fibrinogen (g/1)
Tissue plasminogen
activator (μ§/1)
Plasminogen activator
inhibitor (103 AU/1)
Triacylglycerols (mmol/1)
Total cholesterol (mmol/1)
LDL cholesterol (mmol/1)
HDL cholesterol (mmol/1)
Lipoprotein(a) (mg/1)
Men
N
20
20
20
20
18
19
16
19
19
19
19
20
Women
r
0.04
0.04
-0.12
0.15
0.07
-0.21
-0.01
-0.47
-0.04
-0.15
0.36
0.005
N
14
14
14
14
14
14
10
14
14
14
13
14
r
0.48
0.42
-0.32
0.03
0.15
-0.16
-0.57
0.24
-0.36
-0.24
-0.02
0.18
atherogenic determinants. Table 3 shows the correlations
between initial anthropometric and biochemical quanti-
ties for the total group. Diastolic blood pressure was
significantly correlated with tissue plasminogen activa-
tor concentration in serum (r = 0.46, p < 0.01) while
systolic blood pressure related significantly to total cho-
lesterol (r = 0.55, p < 0.001), LDL cholesterol
(r = 0.58, p < 0.001) and triacylglycerols (r = 0.60,
p < 0.001). Triacylglycerols also Correlated signifi-
cantly with body mass index (r = 0.46, p < 0.01). Cor-
relation analysis between initial values of the haemo-
static and fibrinolytic system and lipid metabolism
showed a significant relation between tissue plasmino-
gen activator and serum triacylglycerols (r = 0.60,
p < 0.001). Finally, the correlation (Spearman) between
changes in lipid and lipoprotein metabolism with
changes in the haemostatic and fibrinolytic system for
the total group are shown in table 4. No significant rela-
tion was found between changes in these biochemical
quantities.
Multiple regression
In the stepwise multiple regression model, dependent
variable was the change in Wmax after nine months
(AWmax). Independent variables for AWmax were initial
body weight, body mass index, diastolic and systolic
blood pressure. Using these independent variables, the
regression equation had an R2 value of 0.33 (N = 34).
In the stepwise multiple regression model however, no
independent variables were selected for AWmax.
Discussion
Several epidemiological studies have revealed that a
sedentary lifestyle is an independent risk factor for coro-
nary heart disease, while habitual physical activity may
reduce the individual risk for this condition (6, 18—21).
The protective effect of exercise seems to be mediated
through favourable influences on several established an-
thropometric and biochemical risk factors (19, 27, 33).
Tab. 3 Spearman's rank coefficient of correlation between initial anthropometric variables and initial
blood properties in the total group (N = 34).
Fibrinogen (g/1)
Tissue plasminogen activator (μ§/1)
Plasminogen activator inhibitor (103 AU/1)
Triacylglycerols (mmol/1)
Total cholesterol (mmol/1)
LDL cholesterol (mmol/1)
HDL cholesterol (mmol/1)
Lipoprotein(a) (mg/1)
Age
(a)
0.02
0.29
-0.10
0.19
0.32
0.41
0.13
-0.09
wmax
(Watt)
-0.39
0.13
0.07
0.17
-0.02
0.14
-0.37
-0.17
Weight
(kg)
-0.18
0.34
0.36
0.36
0.05
0.20
-0.39
-0.15
Body
mass
index
(kg/m2)
0.12
0.32
0.21
0.46a
0.27
0.36
-0.12
0.05
Diastolic
blood
pressure
(mmHg)
0.09
0.46a
0.08
0.32
0.19
0.28
-0.25
-0.12
Systolic
blood
pressure
(mm Hg)
0.01
0.39
0.03
0.60b
0.55b
0.58b
0.02
0.14
1 P < 0.01; b p < 0.001
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Tab. 4 Spearman's rank coefficient of correlation between
changes (Δ) in quantities of the lipid metabolism and changes (Δ)
in factors of the haemostatic and fibrinolytic system after nine
months of training in the total group (N = 34).
Δ Fibrinogen (g/1)
Δ Tissue plasminogen activator (ug/l)
Δ Plasminogen activator inhibitor (iO3 AU/1)
Δ Triacyl-
glyerols
(mmol/1)
0.24
0.09
-0.15
Δ Total
cholesterol
(mmol/1)
-0.13
-0.04
-0.06
Δ Low density
lipoprotein
cholesterol
(mmol/1)
-0.13
0.28
0.08
Δ High density
lipoprotein
cholesterol
(mmol/1)
0.29
-0.16
0.15
Δ Lipo-
protein(a)
(mg/1)
-0.19
-0.03
0.10
Vigourous physical activity may directly or indirectly
influence body weight, blood pressure and the lipid
status (22, 24). Furthermore, beneficial effects of inten-
sive exercise on the haemostatic system are described
(23, 25). Nowadays, whether the intensity of exercise
training, attainable for the majority of people, will pro-
voke similar results, is a topic of investigation (6, 10,
28,32,41,42).
In our study a nine months exercise programme of mod-
erate intensity resulted in a median Wmax increase of 24
Watt (12%) in men and 25 Watt (18%) in women. Al-
though aerobic fitness is commonly expressed as maxi-
mal oxygen uptake (VO2max), Wmax is a more stable de-
terminant for aerobic endurance capacity and easier to
assess in the laboratory (43). Results of other studies, in
which previously sedentary individuals participated in
an aerobic training programme of moderate intensity,
showed increases in VO2max of 10-20% (30, 41, 42).
These results are comparable with the results of the pre-
sent study, since VO2max and Wmax are linearly interre-
lated (43,44). The nine months training programme pro-
voked, besides increases in Wmax at all participants, sev-
eral changes in selected risk factors. However, the
change in aerobic endurance capacity was not signifi-
cantly correlated with changes in anthropometric vari-
ables or changes in lipid and haemostatic properties.
Furthermore, in the stepwise multiple regression model,
no initial anthropometric variables were independent
predictors for the changes of Wmax. So, an active life
style and physical conditioning by itself influences risk
factors, irrespective of anthropometric characteristics or
the outcome of the training sessions (10, 12, 20, 27,45).
Regular physical activity can lower mean resting blood
pressure in moderately hypertensive patients, although
this finding is not universal (46-48). In our study, no
significant changes were found in diastolic or systolic
blood pressure at the end of the training programme in
either men or women. However, one can doubt whether
a fall in blood pressure in healthy normotensive subjects
is likely to be expected (41,42,43,49). The nine months
training programme induced a significant decrease in
median body weight and body mass index in the male
group, as well as a non-significant reduction of body
weight and body mass index in the female group. This
finding can be explained by the increased energy expen-
diture of the individuals under investigation as a result
of the regular training sessions (24,33). Before the train-
ing programme, initial total cholesterol, LDL cholesterol
and triacylglycerol levels correlated significantly with
the systolic blood pressure in the total group, while the
diastolic blood pressure was significantly correlated to
tissue plasminogen activator. Furthermore, a significant
relation between tissue plasminogen activator and tria-
cylglycerols was found. Hypofibrinolysis in patients
with hyperlipidaemia has been frequently reported (50-
53). Also a high blood pressure seems to influence fibri-
nolysis (54, 55). The results of the present study focus
on the important interplay between primary risk factors,
like blood pressure and lipid levels with fibrinolysis
(54). The changes in the haemostatic, fibrinolytic and
lipid status as a result of long-term training programme
has been separately discussed before (56—59). The fall
in plasma plasminogen activator inhibitor levels, ob-
served in both men and women and the significant
decrease in total cholesterol, LDL cholesterol and tria-
cylglycerols in the group of men after nine months of
training are known favourable effects of physical condi-
tioning (26, 27, 30, 33, 63). The changes in these vari-
ables were not interrelated, stressing the fact that these
properties as risk factors for atherosclerotic disease be-
have independently (61). Lipoprotein(a), an LDL like
lipoprotein, competes with plasminogen for fibrin bind-
ing in vitro, and therefore may relate atherosclerosis to
thrombosis (14—17). Although some studies report an
association between lipoprotein(a) levels and fibrinogen
concentrations, most investigators failed to find any re-
lation between lipoprotein(a) and factors of the haemo-
static or fibrinolytic system (62—64). Also in the present
study, the increases in lipoprotein(a) levels in both
groups and the increases in fibrinogen levels in the male
group at the end of the training programme were not
correlated. Lipoprotein(a) levels are often increased in
patients suffering from coronary heart disease (16, 65).
Recently lipoprotein(a) levels in sera of healthy physi-
cally active individuals were found to be raised, which
parallels the results of the present study (66). Therefore,
lipoprotein(a) may play a physiological role as an acute
phase reactant in tissue repair, making its function not
solely restricted to be an atherogenic determinant (66,
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67). In the present study, the training sessions in prepara-
tion for the half marathon run probably have caused physi-
cal stress on the body of the participants, inducing a rise
in lipoprotein(a) and also in fibrinogen as acute phase re-
actants (66-69). Finally, the present study was restricted
to a selected group of healthy volunteers and most pre-
training metabolic properties of the individuals were in
the normal reference range. Therefore the impact .of the
results of this training programme could only be limited.
Taking this in consideration, the effect of physical condi-
tioning on the risk factor profile should be more pro-
nounced in individuals with slight to moderate increased
risk to cardiovascular disease. Further research on this
subject should therefore include patients with an elevated
risk factor profile. Furthermore, longer exercise pro-
grammes and larger study groups may be needed to get
effects comparable with cross-sectional studies.
In conclusion, the results of the present study show that
regular physical conditioning of moderate intensity in-
fluences coronary risk factors at rest. These changes are
more pronounced in men than in women. Improvement
of anthropometric factors, lipid profile and fibrinolytic
potential are important favourable effects. Supposed ad-
verse effects of exercising, like increases in lipopro-
tein(a) and fibrinogen, could actually be a normal
physiological response to the physical strain of the exer-
cise programme of increasing workload.
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